Deyanira Corzo

2.8k total citations
25 papers, 1.5k citations indexed

About

Deyanira Corzo is a scholar working on Physiology, Molecular Biology and Rheumatology. According to data from OpenAlex, Deyanira Corzo has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Molecular Biology and 8 papers in Rheumatology. Recurrent topics in Deyanira Corzo's work include Lysosomal Storage Disorders Research (10 papers), Glycogen Storage Diseases and Myoclonus (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Deyanira Corzo is often cited by papers focused on Lysosomal Storage Disorders Research (10 papers), Glycogen Storage Diseases and Myoclonus (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Deyanira Corzo collaborates with scholars based in United States, United Kingdom and France. Deyanira Corzo's co-authors include Priya S. Kishnani, Marc Nicolino, Hanna Mandel, Wuh‐Liang Hwu, Florence H. Yong, Beth L. Thurberg, Susan Richards, David S. Millington, Sarah P. Young and Yuting Chen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PEDIATRICS.

In The Last Decade

Deyanira Corzo

24 papers receiving 1.5k citations

Peers

Deyanira Corzo

PHYSI

RHEUM

EPIDE

Julian Raiman Canada

Ana Cristina Puga United States

Müge Güçsavaş‐Çalıkoğlu United States

Tarekegn Geberhiwot United Kingdom

Ai-Chu Huang Taiwan

Juan Politei Argentina

J. Ledvinová Czechia

Helena Poupětová Czechia

Maryam Banikazemi United States

Carolina Fischinger Moura de Souza Brazil

Julian Raiman Canada

Deyanira Corzo

738 ×0.7

PHYSI

439 ×0.6

RHEUM

559 ×1.4

181 ×0.6

331 ×1.3

EPIDE

Citations per year, relative to Deyanira Corzo Deyanira Corzo (= 1×) peers Julian Raiman

Countries citing papers authored by Deyanira Corzo

Since Specialization

Citations

This map shows the geographic impact of Deyanira Corzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deyanira Corzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deyanira Corzo more than expected).

Fields of papers citing papers by Deyanira Corzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deyanira Corzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deyanira Corzo. The network helps show where Deyanira Corzo may publish in the future.

Co-authorship network of co-authors of Deyanira Corzo

This figure shows the co-authorship network connecting the top 25 collaborators of Deyanira Corzo. A scholar is included among the top collaborators of Deyanira Corzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deyanira Corzo. Deyanira Corzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gaudet, Daniel, Erik S.G. Stroes, Julie Méthot, et al.. (2016). Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis. Human Gene Therapy. 27(11). 916–925. 82 indexed citations

Patt, Debra A., et al.. (2015). Treatment of metastatic breast cancer with nab-paclitaxel in the community practice setting: a US oncology survey. The Journal of Community and Supportive Oncology. 13(5). 173–180. 1 indexed citations

Corzo, Deyanira, et al.. (2015). Advances in HLA Genetics. PubMed. 12(3). 156–170. 1 indexed citations

Liang, Caihua, Ling Li, Amy Ko, et al.. (2015). The treatment patterns, efficacy, and safety of nab®-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis. BMC Cancer. 15(1). 1019–1019. 23 indexed citations

Andersen, Erica, John C. Carey, Dawn Earl, et al.. (2013). Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf–Hirschhorn Syndrome. European Journal of Human Genetics. 22(4). 464–470. 30 indexed citations

Garrison, Louis P., Hui Huang, Hongliang Shi, et al.. (2013). The Cost-Effectiveness of Initial Treatment of Multiple Myeloma in the U.S. With Bortezomib Plus Melphalan and Prednisone Versus Thalidomide Plus Melphalan and Prednisone or Lenalidomide Plus Melphalan and Prednisone With Continuous Lenalidomide Maintenance Treatment. The Oncologist. 18(1). 27–36. 50 indexed citations

Miguel, Jesús F. San, Paul G. Richardson, Robert Z. Orlowski, et al.. (2011). Risk of Second Primary Malignancies (SPMs) Following Bortezomib (Btz)-Based Therapy: Analysis of Four Phase 3 Randomized Controlled Trials in Previously Untreated or Relapsed Multiple Myeloma (MM). Blood. 118(21). 2933–2933. 8 indexed citations

Niesvizky, Rubén, Ian W. Flinn, Robert M. Rifkin, et al.. (2010). Patient-Reported Quality of Life In Elderly, Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib-Based Regimens: Results From the Phase 3b UPFRONT Study. Blood. 116(21). 3026–3026. 3 indexed citations

Niesvizky, Rubén, Ian W. Flinn, Robert M. Rifkin, et al.. (2010). Phase 3b UPFRONT Study: Safety and Efficacy of Weekly Bortezomib Maintenance Therapy After Bortezomib-Based Induction Regimens In Elderly, Newly Diagnosed Multiple Myeloma Patients. Blood. 116(21). 619–619. 27 indexed citations

10.

Young, Sarah P., Haoyue Zhang, Deyanira Corzo, et al.. (2009). Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker. Genetics in Medicine. 11(7). 536–541. 72 indexed citations

11.

Niesvizky, Rubén, James A. Reeves, Ian W. Flinn, et al.. (2009). Phase 3b UPFRONT Study: Interim Results From a Community Practice-Based Prospective Randomized Trial Evaluating Three Bortezomib-Based Regimens in Elderly, Newly Diagnosed Multiple Myeloma Patients.. Blood. 114(22). 129–129. 6 indexed citations

12.

Wokke, John H. J., Diana M. Escolar, Alan Pestronk, et al.. (2008). Clinical features of late‐onset Pompe disease: A prospective cohort study. Muscle & Nerve. 38(4). 1236–1245. 132 indexed citations

13.

Kallwass, Helmut, Robert J. Pomponio, Deeksha Bali, et al.. (2007). Rapid diagnosis of late-onset Pompe disease by fluorometric assay of α-glucosidase activities in dried blood spots. Molecular Genetics and Metabolism. 90(4). 449–452. 46 indexed citations

14.

Case, Laura E., Donald P. Frush, Stephanie DeArmey, et al.. (2007). Fractures in children with Pompe disease: a potentiallong-term complication. Pediatric Radiology. 37(5). 437–445. 24 indexed citations

15.

Smith, Wendy E., et al.. (2007). Sibling phenotype concordance in classical infantile Pompe disease. American Journal of Medical Genetics Part A. 143A(21). 2493–2501. 15 indexed citations

16.

Ross, Allison Kinder, Jennifer S. Li, Stephanie DeArmey, et al.. (2007). Cardiac arrhythmias following anesthesia induction in infantile‐onset Pompe disease: a case series. Pediatric Anesthesia. 17(8). 738–748. 36 indexed citations

17.

Kishnani, Priya S., Wuh‐Liang Hwu, Hanna Mandel, et al.. (2006). A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. The Journal of Pediatrics. 148(5). 671–676.e2. 445 indexed citations

18.

Kishnani, Priya S., Marc Nicolino, Thomas Voït, et al.. (2006). Chinese hamster ovary cell-derived recombinant human acid α-glucosidase in infantile-onset Pompe disease. The Journal of Pediatrics. 149(1). 89–97. 220 indexed citations

19.

An, Yan, Sarah P. Young, Priya S. Kishnani, et al.. (2005). Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease. Molecular Genetics and Metabolism. 85(4). 247–254. 68 indexed citations

20.

Corzo, Deyanira, William T. Gibson, Grant A. Mitchell, et al.. (2002). Contiguous Deletion of the X-Linked Adrenoleukodystrophy Gene (ABCD1) and DXS1357E: A Novel Neonatal Phenotype Similar to Peroxisomal Biogenesis Disorders. The American Journal of Human Genetics. 70(6). 1520–1531. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact